Long - term use of aspirin reduces the risk of many types of cancer

Research has involved over 60,000 people, and according to experiments, the long - term use of aspirin has contributed to reduced risk of developing leukemia, lung cancer, and prostate cancer, Telegraphy is transmitted.

For this study, researchers have compared patients who have been using aspirin for an average of 7.7 years with patients who haven't used aspirin at all, and have looked at the number of patients who have been diagnosed with cancer after several years.

Those who had used aspirin had had a 47 percent reduction in the risk of liver and esophagus cancer, 38 percent reduction in risk of gastric cancer, 34 percent reducing the risk of pancreatic cancer, and 24 percent reducing the risk of bulgal cancer.

Aspirin seems to have had no effect on the risk of breast cancer, bladder, and kidneys.